Browsing tag:

heart failure


Positive studies of the recombinant human relaxin-2, known as Serelaxin, have continued to emerge, offering excitement in the pharmaceutical arena. On October 25, 2013 study data published on Medscape via The Lancet revealed the most recent data from a randomized and placebo controlled trial. This trial, coined RELAX-AHF, aimed to test the hypothesis that patients[…]

Read More

Trandolapril is intended for patients with hypertension, or for anyone who has experienced heart failure post myocardial infarction. Particularly effective for those patients who have left-ventricular dysfunction after a heart attack, trandolapril is an angiotensin-converting enzyme, or ACE inhibitor. Marketed by Abbott as the brand name Mavik, the patent for this lifesaving medication is due[…]

Read More

Carvedilol Phosphate, CAS number 72956-09-3, is known as the blockbuster medication Coreg CR. GlaxoSmithKline holds the patent for Coreg CR until February 7, 2016. Useful for treating patients with hypertension and mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, carvedilol phosphate is available for research and development from LGM Pharma. In the group of[…]

Read More

Carvedilol, CAS# 72956-09-3, is known as the brand name Coreg, which is marketed by GlaxoSmithKline. The patent for Coreg will expire on June 7, 2015, making way for a generic market. As a beta-blocker used to treat hypertension and heart failure, carvedilol is also often prescribed to treat and prevent heart attack symptoms. Carvedilol is[…]

Read More

A study presented at the European Society of Cardiology (ESC) Congress 2010 gives promising results to patients suffering from heart failure with tachycardia (increased heart rate). The study, called Systolic Heart Failure Treatment with If Inhibitor Ivabradine Trial (SHIFT), provided scientists with a strong case for ivabradine’s usefulness as an adjunct agent in the treatment[…]

Read More

This website uses cookies. By using our site, you agree to our terms of service